Edgar Tracker

PROK PROKIDNEY CORP.

Nasdaq · CIK 1850270 · Biological Products, (No Diagnostic Substances)

SEC company page

Public articles

No public articles yet. Follow PROK to track filings and write notes.

Recent filings

–

Form Filed Title Accession
SCHEDULE 13G/A2026-08-12—0000895421-26-000226
8-K2026-08-102.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001193125-26-342397
10-Q2026-08-1010-Q0001193125-26-342373
32026-06-1030001193125-26-265815
8-K2026-05-295.07 Submission of Matters to a Vote of Security Holders0001193125-26-248210
8-K2026-05-152.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-225848
10-Q2026-05-1510-Q0001193125-26-225841
SCHEDULE 13D/A2026-04-30—0001140361-26-018258
ARS2026-04-17ARS0001140361-26-015371
DEFA14A2026-04-17DEFA14A0001140361-26-015369
DEF 14A2026-04-17DEF 14A0001140361-26-015362
S-82026-03-18S-80001193125-26-113942
8-K2026-03-182.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001193125-26-113893
10-K2026-03-1810-K0001193125-26-113881
SCHEDULE 13G2026-02-12—0000895421-26-000066
8-K2026-02-027.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001193125-26-033594
8-K2026-01-127.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits0001193125-26-009807
EFFECT2025-11-18—9999999995-25-003304
8-K2025-11-102.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0001193125-25-274314
10-Q2025-11-1010-Q0001193125-25-274303